Form 4 Tracker
Frank Mccormick

Director · 2 filings · Latest: Jun 22, 2026

BridgeBio Oncology Therapeutics, Inc.
BridgeBio Pharma, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BBIO
Frank McCormick—Oct 29, 2025
Proposed Sale
$66.58198,359$13.2M—
BBIO
Frank McCormick—Oct 27, 2025
Proposed Sale
$65.001,641$106.7K—
BBIO
FRANK P. MCCORMICK—Sep 5, 2025
Proposed Sale
$53.1474,000$3.9M—
BBIO
MCCORMICK FRANK—Jun 24, 2025
Proposed Sale
$44.23100,000$4.4M—